Market Signal Briefing

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws.

If you invested in Freeport, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit.

Investors have until January 12, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Freeport securities. The case is pending in the U.S. District Court for the District of Arizona and is captioned Reed v. Freeport-McMoRan Inc., et al., No. 2:25-cv-04243.

Why is Freeport Being Sued For Securities Fraud?

Freeport is a mining company with its Indonesian affiliate operating as PT Freeport Indonesia (“PTFI”). PTFI operates the Grasberg Copper and Gold Mine (“Grasberg”), in which the Indonesian government holds a commercial interest. During the relevant period, Freeport touted its safety procedures, including its use of data and technology as well as behavioral science principles to prevent fatal incidents. It indicated it provides the training, tools, and resources needed to identify risks and consistently apply effective controls.

As alleged, in truth, Freeport overstated its commitment to safety, given that it conducted unsafe mining practices at the Grasberg mine which were reasonably likely to result in worker fatalities.

Why did Freeport’s Stock Drop?

On September 9, 2025, Freeport issued a press release on its PTFI operations. It announced that mining operations in Grasberg had been suspended to evacuate seven team members that were trapped due to a landslide at one of its underground mines. This news caused the price of Freeport stock to drop $2.77 per share, or more than 5.9%, from a closing price of $46.66 per share on September 8, 2025, to $43.89 per share on September 9, 2025.

On September 24, 2025, Freeport issued an update on the incident noting that two of the seven individuals had been fatally injured and that the remaining five team members remained missing. In the same release, Freeport noted that due to the suspension in operations, sales were expected to be 4% lower for copper and approximately 6% lower for gold than July 2025 estimates. This news caused the price of Freeport stock to drop $7.69 per share, or almost 17%, from a closing price of $45.36 per share on September 23, 2025, to $37.67 per share on September 24, 2025.

Then, on September 25, 2025, Bloomberg reported that the incident and halt in production was straining the relationship between Freeport and Indonesia, that “the Jakarta government [had already been] looking to take greater control,” and that government officials may increase its demand for an increased share. This news caused the price of Freeport stock to drop $2.33 per share, or more than 6%, from a closing price of $37.67 per share on September 24, 2025, to $35.34 per share on September 25, 2025.

Finally, on September 28, 2025, an Indonesian news organization reported that the incident was preventable, not just a natural disaster. The article quotes an Indonesian professor stating that “the landslide, often termed a mud rush, is a known flow of mud and rocks from the mine cavity, a risk long associated with certain mining methods.” The professor stated, “[i]n other words, this danger is not new and should have been anticipated from the beginning[.]”

Click here for more information: https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit.

What Can You Do?

If you invested in Freeport you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit

Or contact:
Ross Shikowitz
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Beyond Meat, Inc. (NASDAQ: BYND) for potential violations of the federal securities laws.

If you invested in Beyond Meat, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/beyond-meat-inc-class-action-investigation.

Why Is Beyond Meat Being Investigated for Securities Fraud?

Beyond Meat makes plant-based meat alternatives. In late 2023, the company went through a global operations review and depreciated certain long-lived assets. Beyond Meat said that these assets were recorded in assets held for sale in its consolidated balance sheet at the lower of their carrying value or fair value less costs to sell, and that there were no impairments.

BFA is investigating whether Beyond Meat inflated the value of certain long-lived assets.

Why Did Beyond Meat’s Stock Drop?

On October 24, 2025, Beyond Meat announced that it “expects to record a non-cash impairment charge for the three months ended September 27, 2025, related to certain of its long-lived assets,” which it “expected to be material.” On this news, the price of Beyond Meat stock dropped roughly 23%, from $2.84 per share on October 23, 2025 to $2.185 per share on October 24, 2025.

Then, on November 3, 2025, the company delayed its earnings announcement for 3Q 2025 as it needed more time to complete the impairment review. This news caused Beyond Meat stock to decline substantially during the trading day on November 3, 2025.

Finally, on November 10, 2025, Beyond Meat reported its 3Q 2025 Earnings. It announced that losses from operations was $112.3 million, which included a “$77.4 million in non-cash impairment charges related to certain of the Company’s long-lived assets.”

Click here for more information: https://www.bfalaw.com/cases/beyond-meat-inc-class-action-investigation.

What Can You Do?

If you invested in Beyond Meat you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

Or contact:
Ross Shikowitz
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

Attorney advertising. Past results do not guarantee future outcomes.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another.

Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a technical analyst for Dow Jones Newswires and as the senior market analyst with TraderPlanet.com. Jim is also a consultant with the highly respected "Pro Farmer" agricultural advisory service. Jim was also the head equities analyst at CapitalistEdge.com. He received his degree from Iowa State University in Ames, Iowa, where he studied journalism and economics.

Follow Jim daily on Kitco.com as he provides both AM and PM roundups and a daily Technical Special.
1 877 963-NEWS
jwyckoff at kitco.com

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company” and “Cross Country”) (Nasdaq: CCRN) today announced that John A. Martins, the Company's President and Chief Executive Officer, has separated from the Company and ceased to serve as a member of its Board of Directors (the “Board”), effective as of December 14, 2025. The Board appointed Kevin C. Clark, the Company's current Chairman, former Chief Executive Officer, and Co-Founder, to succeed Mr. Martins as the Compan.

NEW YORK--(BUSINESS WIRE)--Ladder Capital Corp (“Ladder” or the “Company”) (NYSE: LADR) today announced the declaration by its board of directors of a fourth quarter 2025 dividend of $0.23 per share of Class A common stock. The cash dividend is payable on January 15, 2026 to stockholders of record as of the close of business on December 31, 2025. About Ladder Ladder is a publicly listed, investment grade-rated commercial real estate finance company with a diversified, nationwide platform. We de.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine secures FDA clearance for new DWI sequence, significantly expanding the Swoop® system's clinical capabilities in acute neurological care.

AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today announced the general availability of Falcon® AI Detection and Response (AIDR), extending the Falcon® platform to secure the fastest-growing attack surface in the AI era: the AI prompt and agent interaction layer. With Falcon AIDR, CrowdStrike delivers the industry's first unified platform that secures every layer of enterprise AI – data, models, agents, identities, infrastructure, and interactions – from development through workf.

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws.

If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit.

Why is BellRing Being Investigated?

BellRing Brands operates in the convenient nutrition category. The Company’s primary brands include Premier Protein and Dymatize, which offer ready-to-drink (“RTD”) protein shakes and powders. During the relevant period, the Company stated that Premier Protein “hit an all-time high in household penetration” and that “demand remains strong.” The Company also stated that its growth was “strong in all channels,” driven by “distribution expansion, accelerating velocities and incremental promotional activity.”

In truth, the Company’s sales growth during the relevant period may have been driven by temporary trade inventory loading at several key retailers, not sustainable end-consumer demand.

The Stock Declines as the Truth Is Revealed

On May 5, 2025, after market hours, BellRing revealed that starting in Q2 2023, “several key retailers lowered their weeks of supply on hand,” which would create a headwind to Q3 2025 growth. The Company also announced it was expanding promotions to boost sales and “offset [] third quarter reductions in retailer trade inventory levels.” On this news, the price of BellRing stock fell $13.96 per share, or more than 18%, from $77.34 per share on May 5, 2025, to $63.38 per share on May 6, 2025.

Then, on August 4, 2025, after market hours, BellRing announced disappointing quarterly consumption of Premier Protein RTD Shakes, which had been expected to outpace shipments by a wider margin given previously announced retailer destocking, but instead came “more in line” with shipments. On this news, the price of BellRing Brands stock fell $17.46 per share, or nearly 33%, from $53.64 per share on August 4, 2025, to $36.18 per share on August 5, 2025.

Click here for more information: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit.

What Can You Do?

If you invested in BellRing you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit

Or contact:
Ross Shikowitz
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

Preliminary Data Shows Platform Generated Over $1.36 Million in Just 14 Days; Daily Revenue Velocity Accelerating Rapidly Month-over-Month

SCOTTSDALE, ARIZONA / ACCESS Newswire / December 15, 2025 / Bonk, Inc. (Nasdaq:BNKK) today released preliminary performance data from its primary revenue-generating asset, BONK.fun. The data, which can be verified via third-party analytics provider DeFiLlama (https://defillama.com/protocol/letsbonk.fun), reveals an explosive breakout in platform activity, with the daily revenue run rate increasing by approximately 700% closing out the first two weeks of December compared to the same period in November.

Total revenue for the period (December 1-14) reached approximately $1.36 million, more than doubling the $519,000 generated during the first two weeks of November.

Key Performance Metrics

Revenue Surge: Total revenue for the first two weeks of December hit ~$1.36 million, up from ~$519,000 in the prior month's period (+162%).

Explosive Exit Velocity: Daily revenue accelerated significantly throughout the period, reaching peaks of over $178,000 per day in mid-December, compared to lows of ~$12,000 in mid-November-a 700%+ increase in revenue velocity.

Sustained Step-Function Change: This is not merely a temporary spike; the data indicates a structural step-function change in platform usage. The daily revenue "floor" (daily minimum) has moved up to approximately $80,000 for the trailing week, compared to lows of ~$12,000 in November. Management views this new baseline as highly favorable for future revenue forecasting.

Financial Impact: As the holder of a 51% majority revenue interest, Bonk, Inc. is the primary beneficiary of this windfall. This surge in cash flow is expected to materially impact Q4 financial results and accelerate the Company's treasury accumulation strategy.

Transforming Shareholder Value This surge represents a step-function change in the Company's financial profile compared to the prior fiscal year. By consolidating 51% of a platform now generating ~$1.36 million in a two-week period, Bonk, Inc. has secured a high-margin revenue stream that creates clear separation from its historical financial performance. Furthermore, because ecosystem revenue is structurally linked to token burns, this massive spike in volume acts as a hyper-deflationary event, reducing global supply and enhancing the fundamental scarcity of the assets held in the Company's treasury. Management believes this creates tangible shareholder value by replacing speculative forecasts with proven, accelerating cash flow that will drive revenue figures significantly higher year-over-year.

Management Commentary "The numbers we are seeing from BONK.fun are nothing short of explosive," said Jarrett Boon, CEO of Bonk, Inc. "Generating over $1.36 million in just two weeks-with daily peaks hitting $178,000-validates our thesis that the BONK ecosystem is a coiled spring. A 700% surge in our run rate isn't just growth: it's a regime change. We positioned the public company to capture exactly this kind of upside, and now the results are showing up in the data."

About Bonk, Inc. Bonk, Inc. (Nasdaq: BNKK) is a company evolving to bridge the gap between traditional public markets and the digital asset ecosystem. Through its subsidiary BONK Holdings LLC, the Company executes a strategy focused on acquiring revenue-generating assets within the decentralized finance space. The Company also operates a growing beverage division holding the patented Sure Shot and Yerbaé brands.

Investor Relations Contact: Phone: 888.257.8061 Email: [email protected]

Forward-Looking Statements: This press release contains forward-looking statements. Such statements are subject to risks and uncertainties, and actual results could differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the performance of BONK digital assets, the operational success of the beverage division, market volatility, and other risks detailed in Bonk, Inc.'s filings with the Securities and Exchange Commission.

SOURCE: Bonk, Inc.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Shares of Tesla Inc. (NASDAQ:TSLA) gained 2.61% over the past five trading sessions after gaining 6.98% the five prior. A rally that began in early summer has pushed the stock into the green on the year, but the AI-induced sell-off that began in late October and carried deep into November tempered Tesla’s performance this fall. Overall this year, the stock is up 21.01 in 2025%. Since hitting its all-time high on Dec. 17, 2024, the stock has fallen 4.36%.

When the company reported Q3 earnings on Oct. 22, 2025, it announced quarterly revenue of $28.1 billion, up 12% year-over-year (YoY). However, earnings of 50 cents per share missed analysts’ estimates of 54 cents per share. Concerningly, quarterly net income fell 37% YoY to $1.37 billion. 

Tesla’s stock has gone through vicious crashes before. And while the stock may not be ready to shift gears from reverse to forward, I do think that a worsening of its latest drawdown could prove a significant buying opportunity, given the chance its drivers could pay off at some point over the medium term. Undoubtedly, the bears may be winning the tug-of-war on the stock now, as Elon Musk’s role at DOGE (Department of Government Efficiency) becomes old news as hype surrounding Musk’s friendship with Trump begins to fade. However, with EV competition mounting and a Jeff Bezos-backed startup entering the scene, Tesla’s outlook remains clouded.

In any case, 24/7 Wall St. dove into the lengthy list of drivers and potholes that investors should look forward to (or fasten their seatbelts for) in the coming year and beyond. Let’s check out a bull, bear, and base case for the EV titan and have a glimpse at the varied viewpoints of multiple Wall Street pros. In fact, Tesla stock has a ton of table-pounding bulls in addition to massive bears. While not everyone is the biggest fan of Elon Musk, I do think it’s a mistake to discount his ability to keep running with the ball into the endzone with disruptive innovations that, while costly in the near term, could prove revolutionary over the longer term. 

Tesla’s Top Two Growth Drivers Are Still Humming Along

For a stock that’s fallen significantly, I’d expect the growth narrative to have been severely impacted. Tesla’s latest quarterly earnings results were not incredible. Yet, I do think that the sell-off is mostly a mere correction to make up for the euphoric melt-up experienced in the back half of last year. Indeed, investors got too far ahead of themselves when it came to Tesla’s most ambitious growth drivers. Now that investors are taking a step back, we’ll have to wait and see if Tesla can advance such drivers meaningfully.
Undoubtedly, Tesla has a front-row seat to the AI revolution. More specifically, it’s one of the frontrunners in physical AI (or robotics, if you prefer). In a prior piece, I highlighted Wall Street analyst Adam Jonas’ view that TSLA stock was akin to an embodied “AI ETF” given the numerous AI projects going on behind the scenes.

Though Tesla’s AI efforts are exciting, it’s important to note that being too soon to a trend could have a drastic negative impact on the stock. As investors reset expectations and become more critical of how firms spend money on AI, Tesla will need to deliver more substance if it’s to convince investors to punch their ticket to the stock well ahead of time. Personally, I think Tesla’s been investing in the right areas, but will competitors beat Tesla to market in certain categories? 

The most notable drivers, I believe, that will drive Tesla stock in the coming years are the Cybertruck (as well as self-driving capabilities and the impact on the robotaxi market) and its Optimus robot. Of course, there’s also the rumored “Model Q” entry-level offering. But until we get more clarity on that driver, I consider it to be more of a “wild card.”

Bull Case for Tesla’s Share Price
Cybertruck: The Cybertruck stole the show during Tesla’s robotaxi event. While it would be a sci-fi dream for many to have a fairly reasonably priced robotaxi producing passive income for its owners, I do think Musk’s vision of the robotaxi future could be a reality within Trump’s term. Of course, a more realistic timeframe would put such a future more than 10 years out.

However, if Tesla can floor it on full self-driving (FSD) efforts, perhaps such a future could be closer to the present. There’s a great deal of uncertainty with FSD, given the technical and regulatory unknowns. Either way, I view Musk’s friendship with Trump as a boon for a Cybertruck rollout under his administration.

If Cybertruck expands its presence and becomes a hit within years rather than decades, TSLA stock could prove a bargain, given all that there is to gain. The big question, though, is how Cybercab will hold its own as Waymo pushes ahead with its impressive offering. Given robotaxis, like generative AI, are unlikely to be a “winner takes all” market, I think there’s no reason why both robotaxi offerings can’t win big from prime-time adoption of self-driving. 

Another big question to consider is whether consumers will be interested in buying up Cybercabs to have them rolling around on the streets as ride-hailers. I think the business could prove quite lucrative for buyers and Tesla’s margins over the long haul. After all, it can sell the car and continue to build a ride-hailing network while profiting from use of a ride-hailing app of sorts.

Cathie Wood thinks autonomous ride-hailing could represent a multi-trillion-dollar opportunity. If Tesla can get a nice slice, Wood sees TSLA stock at $2,600 per share by 2029. Personally, I think the bull case (for the year ahead) could see TSLA at around $550 per share — or 33.67% higher than where the stock is trading today. That target is shared by Wedbush Securities’ Dan Ives, one of my favorite analysts in tech.

Optimus: Optimus was a nice addition to the robotaxis event as it amused attendees. But the big question is how much potential the robot has once it’s ready to go on sale to the general public.

Undoubtedly, Tesla isn’t the only one getting into the robotics game. Many Mag Seven members also investing heavily in home robots. While more rivals in home robots could be a threat to Optimus, I view it as more of a confirmation that there is a place in the home for such profound innovations.

As for the home robotics market, I do see 2026 as a tad overly optimistic for a launch. However, if robot “friends” do arrive by 2030, I think Tesla’s growth rate could reaccelerate back to or even above 25% to 30% for some amount of time.

Analysts’ Price Targets: So far this fall and during summer, the EV firm underwent a series of price target revisions from analysts. Stifel raised its price target on Tesla to $483 from $440 keeping its “Buy” rating while citing progress in its Robotaxi network. Canaccord raised its price target on Tesla to $490 from $333 keeping its “Buy” rating. In September, Mizuho raised its price target on Tesla to $450 from $375 while keeping an “Outperform” rating. In July, Goldman Sachs raised its price target on TSLA to $315 from $285 while maintaining a “Neutral” rating. Benchmark raised its price target on TSLA to $475 from $350 while maintaining a “Buy” rating following the successful launch of Tesla’s robotaxi business in Austin. UBS raised its price target on TSLA to $215 from $190 but maintained its “Sell” rating. 

Bear Case for Tesla’s Share Price
Cybertruck: Undoubtedly, there’s still a lot of work to do before Cybertruck makes an impact on the car market. FSD capabilities need to step things up and the vehicle needs to be made in a way that won’t break the bank. These are big asks. Some bears have doubts about whether the firm can execute the opportunity. In late March, the company announced that it was recalling nearly every Cybertruck due to a potential crash risk. This was an enormous blow to Musk’s ambitions for the EV, which has already been subjected to harsh criticism about its perceived shortcomings among owners. 

Bad Press: Musk’s deteriorated image at the hands of his federal government involvement with DOGE aside, Tesla has continued to bear the brunt of bad news. In late 2024, it was widely reported that the EV maker was the most dangerous vehicle brand, with the number of deaths among all automakers, according to the Insurance Institute of Highway Safety. According to the study, Tesla has a fatal accident rate of 5.6 per billion vehicle miles, compared to the overall average of just 2.8. Additionally, ongoing protests against the brand — including vandalism and arson — have occurred around the globe, from Italy and France to numerous states in the U.S.

Optimus: Even if home robots are on the horizon, good luck asking consumers to spend thousands on a proven technology. Indeed, if Vision Pro taught us anything, it’s that being an early adopter is expensive and probably not the best use of funds. Either way, I’d much rather wait and see how the robot ambitions pan out before getting too excited at this stage.

Insider & Institutional Activity: There’s an old adage on Wall Street that suggests investors should “follow the money.” If that’s the current case for Tesla, money is flowing out. In fact, over the past three months, not a single share of TSLA has been purchased by insiders (e.g., the company’s executives, directors or anyone who owns 10% or more of the company), and over the past 12 months, there has only been one insider purchase, according to Nasdaq.com. Data from Finviz supports this, even showing that Musk himself, as well as his brother, have been offloading shares since late 2024. Additionally, institutional ownership has now decreased to 48.11%. In total, 117 institutional investors have entirely liquidated their Tesla positions over the past year. 

Increased competition: Also in April, a Jeff Bezos-backed EV company called Slate unveiled affordable EV truck and SUV models, which the company aims to sell at a cost of around $30,000. The company has billed itself as the “anti-Tesla,” and is made in the U.S. As Tesla’s market share has fallen under 50% in EV-friendly California, the arrival of Slate could continue to erode sales. 

Base Case for Tesla’s Share Price

The base case for Tesla lies somewhere in between the two extremes. Wall Street analysts have assigned TSLA a median one-year price target of $383.54, or 16.43% potential downside from today’s price. Meanwhile, the high-end target is $600 and the low-end target is $19.05. I’m inclined to view the $300 level as a fair-value level for the stock. 
Much of Tesla’s story depends on its big growth drivers. In the meantime, EV sales and the rise of more affordable models (Model Q) could be nearer-term stories to look forward to as one waits for the biggest of drivers to pay off. At the time of writing, TSLA stock goes for 220.97 times forward price-to-earnings (P/E) and an 18.7 price-to-book (P/B). That makes the name slightly undervalued, at least in my view. 

HomeETFs and Funds AnalysisClosed End Funds Analysis

SummaryThe Clough Global Opportunities Fund offers a compelling 10.58% yield but has a poor long-term track record of capital preservation.While GLO outperformed major indices over the past seven months, its five-year total return remains negative, lagging nearly all peers.GLO’s high yield relies on capital gains, not portfolio income, making distributions vulnerable in adverse markets and raising sustainability concerns.Exposure to homebuilders and a history of overdistribution warrant caution, despite an attractive discount to NAV and recent performance improvement. design master/iStock via Getty Images

The Clough Global Opportunities Fund (GLO) is a closed-end hybrid equity and bond fund that boasts a very attractive yield today. While that could make this a good investment for income seekers, I urge caution

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I am long physical gold. In this article, I made reference to the GLD ETF, which I do not own.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

SAN DIEGO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Period”), have until Friday, January 16, 2026 to seek appointment as lead plaintiff of the Perrigo class action lawsuit. Captioned French v. Perrigo Company plc, No. 25-cv-09596 (S.D.N.Y.), the Perrigo class action lawsuit charges Perrigo and certain of Perrigo’s top current and former executives with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the Perrigo class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-perrigo-company-plc-class-action-lawsuit-prgo.html

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].

CASE ALLEGATIONS: Perrigo provides over-the-counter health and wellness solutions. According to the complaint, in November 2022, Perrigo acquired Nestlé’s Gateway infant formula plant in Wisconsin, along with the U.S. and Canadian rights to Nestlé’s Good Start® infant formula brand, for $170 million.

The Perrigo class action lawsuit alleges that throughout the Class Period defendants made false and/or misleading statement and/or failed to disclose that: (i) the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs; (ii) Perrigo needed to make substantial capital and operational expenditures above Perrigo’s outwardly stated cost estimates to remediate the infant formula business; (iii) there were significant manufacturing deficiencies in the facility for Perrigo’s infant formula business; and (iv) as a result of the foregoing, Perrigo’s financial results, including earnings and cash flow, were overstated.

The Perrigo class action lawsuit further alleges that on February 27, 2024, Perrigo revealed significant acquisition and integration-related charges, including a purported one-time cash cost of an additional $35 million to $45 million for remediations to address production and facility issues in the infant formula business. Perrigo allegedly further disclosed a 50% decline in earnings per share compared to the prior year due to infant formula remediation actions and that the infant formula business’s full year adjusted operating income was less than half the expected normalized run rate of $140 million per quarter. On this news, the price of Perrigo stock fell more than 15%, according to the complaint.

Then, on May 7, 2024, Perrigo allegedly disclosed “[n]et sales of $91 million decreased 34.5% due primarily to lower shipments to customers as the company works through its infant formula plant remediation plans” and “gross margin of 36.5% declined 90 basis points, including a -280 basis points impact from infant formula.” On this news, the price of Perrigo stock fell nearly 10%, according to the complaint.

Thereafter, on August 6, 2025, the Perrigo class action lawsuit alleges that Perrigo revealed that its adjusted gross profit decreased $30 million, or 6.9%, due in part to “production variability in infant formula leading to an increase in product scrap in the quarter,” and that Perrigo’s reported gross margin was 34.4%, a decrease of 260 basis points “due primarily to the same factors.” On this news, the price of Perrigo stock allegedly fell more than 11%.

Finally, on November 5, 2025, Perrigo allegedly announced it “is initiating a strategic review of its infant formula business” including a “full range of alternatives,” and is “reassessing the Company’s previously announced investment in this business of $240 million.” The complaint further alleges that Perrigo also revealed that “due primarily to infant formula industry dynamics,” Perrigo had slashed its fiscal year 2025 outlook, including its reported net sales growth guidance to -2.5% to -3%, a negative turn from the previously expected 0% to 3%, and its expected adjusted diluted earnings per share to a range of $2.70 to $2.80, equating to a growth of 5% to 9%; a significant cut from the previously expected range of $2.90 to $3.10, equating to growth of 13% to 21%. On this news, the price of Perrigo stock fell more than 25%, according to the complaint.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Perrigo securities during the Class Period to seek appointment as lead plaintiff in the Perrigo class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Perrigo investor class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Perrigo shareholder class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Perrigo class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. 
Services may be performed by attorneys in any of our offices. 

Contact:
        Robbins Geller Rudman & Dowd LLP
        J.C. Sanchez, Jennifer N. Caringal
        655 W. Broadway, Suite 1900, San Diego, CA 92101
        800-449-4900
        [email protected]

If you're interested in broad exposure to the Technology - Broad segment of the equity market, look no further than the Vanguard Information Technology ETF (VGT - Free Report) , a passively managed exchange traded fund launched on January 26, 2004.

While an excellent vehicle for long term investors, passively managed ETFs are a popular choice among institutional and retail investors due to their low costs, transparency, flexibility, and tax efficiency.

Sector ETFs also provide investors access to a broad group of companies in particular sectors that offer low risk and diversified exposure. Technology - Broad is one of the 16 broad Zacks sectors within the Zacks Industry classification. It is currently ranked 1, placing it in top 6%.

Index DetailsThe fund is sponsored by Vanguard. It has amassed assets over $112.16 billion, making it the largest ETF attempting to match the performance of the Technology - Broad segment of the equity market. VGT seeks to match the performance of the MSCI US Investable Market Information Technology 25/50 Index before fees and expenses.

The MSCI US Investable Market Information Technology 25/50 Index is designed to transition in and out of securities affected by pending updates to the information technology sector.

CostsInvestors should also pay attention to an ETF's expense ratio. Lower cost products will produce better results than those with a higher cost, assuming all other metrics remain the same.

Annual operating expenses for this ETF are 0.09%, making it one of the least expensive products in the space.

It has a 12-month trailing dividend yield of 0.41%.

Sector Exposure and Top HoldingsIt is important to delve into an ETF's holdings before investing despite the many upsides to these kinds of funds like diversified exposure, which minimizes single stock risk. And, most ETFs are very transparent products that disclose their holdings on a daily basis.

This ETF has heaviest allocation in the Information Technology sector -- about 100% of the portfolio.

Looking at individual holdings, Nvidia Corp (NVDA) accounts for about 18.18% of total assets, followed by Apple Inc (AAPL) and Microsoft Corp (MSFT).

Performance and RiskYear-to-date, the Vanguard Information Technology ETF return is roughly 21.62% so far, and is up about 18.76% over the last 12 months (as of 12/15/2025). VGT has traded between $470.37 and $801.52 in this past 52-week period.

The ETF has a beta of 1.26 and standard deviation of 23.01% for the trailing three-year period, making it a medium risk choice in the space. With about 317 holdings, it effectively diversifies company-specific risk.

AlternativesVanguard Information Technology ETF holds a Zacks ETF Rank of 1 (Strong Buy), which is based on expected asset class return, expense ratio, and momentum, among other factors. Because of this, VGT is a great option for investors seeking exposure to the Technology ETFs segment of the market. There are other additional ETFs in the space that investors could consider as well.

iShares U.S. Technology ETF (IYW) tracks Dow Jones U.S. Technology Index and the State Street Technology Select Sector SPDR ETF (XLK) tracks Technology Select Sector Index. iShares U.S. Technology ETF has $20.89 billion in assets, State Street Technology Select Sector SPDR ETF has $93.06 billion. IYW has an expense ratio of 0.38%, and XLK charges 0.08%.

Bottom LineTo learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.

The WisdomTree International Hedged Quality Dividend Growth ETF (IHDG - Free Report) was launched on 05/07/2014, and is a smart beta exchange traded fund designed to offer broad exposure to the Broad Developed World ETFs category of the market.

What Are Smart Beta ETFs?For a long time now, the ETF industry has been flooded with products based on market capitalization weighted indexes, which are designed to represent the broader market or a particular market segment.

Market cap weighted indexes offer a low-cost, convenient, and transparent way of replicating market returns, and are a good option for investors who believe in market efficiency.

If you're the kind of investor who would rather try and beat the market through good stock selection, then smart beta funds are your best choice; this fund class is known for tracking non-cap weighted strategies.

By attempting to pick stocks that have a better chance of risk-return performance, non-cap weighted indexes are based on certain fundamental characteristics, or a combination of such.

The smart beta space gives investors many different choices, from equal-weighting, one of the simplest strategies, to more complicated ones like fundamental and volatility/momentum based weighting. However, not all of these methodologies have been able to deliver remarkable returns.

Fund Sponsor & IndexThe fund is managed by Wisdomtree, and has been able to amass over $2.29 billion, which makes it one of the larger ETFs in the Broad Developed World ETFs. IHDG, before fees and expenses, seeks to match the performance of the WisdomTree International Hedged Quality Dividend Growth Index.

The WisdomTree International Hedged Quality Dividend Growth Index is designed to provide exposure to the developed market companies while at the same time neutralizing exposure to fluctuations between the value of foreign currencies and the U.S. dollar.

Cost & Other ExpensesExpense ratios are an important factor in the return of an ETF and in the long-term, cheaper funds can significantly outperform their more expensive cousins, other things remaining the same.

Annual operating expenses for IHDG are 0.58%, which makes it on par with most peer products in the space.

It has a 12-month trailing dividend yield of 2.54%.

Sector Exposure and Top HoldingsETFs offer diversified exposure and thus minimize single stock risk, but it is still important to delve into a fund's holdings before investing. Most ETFs are very transparent products and many disclose their holdings on a daily basis.

Taking into account individual holdings, Us Dollaraccounts for about 95.72% of the fund's total assets, followed by Bp Plc (BP/) and Industria De Diseno Textil (ITX).

IHDG's top 10 holdings account for about 127.42% of its total assets under management.

Performance and RiskSo far this year, IHDG has added about 12.84%, and was up about 9.97% in the last one year (as of 12/15/2025). During this past 52-week period, the fund has traded between $38.54 and $48.33.

The ETF has a beta of 0.75 and standard deviation of 13.20% for the trailing three-year period, making it a medium risk choice in the space. With about 281 holdings, it effectively diversifies company-specific risk .

AlternativesWisdomTree International Hedged Quality Dividend Growth ETF is a reasonable option for investors seeking to outperform the Broad Developed World ETFs segment of the market. However, there are other ETFs in the space which investors could consider.

iShares Core Dividend Growth ETF (DGRO) tracks Morningstar US Dividend Growth Index and the Vanguard Dividend Appreciation ETF (VIG) tracks NASDAQ US Dividend Achievers Select Index. iShares Core Dividend Growth ETF has $35.96 billion in assets, Vanguard Dividend Appreciation ETF has $101.66 billion. DGRO has an expense ratio of 0.08% and VIG changes 0.05%.

Investors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the Broad Developed World ETFs

Bottom LineTo learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.

If you're interested in broad exposure to the Mid Cap Blend segment of the US equity market, look no further than the JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME - Free Report) , a passively managed exchange traded fund launched on May 11, 2016.

The fund is sponsored by J.P. Morgan. It has amassed assets over $385.36 million, making it one of the average sized ETFs attempting to match the Mid Cap Blend segment of the US equity market.

Why Mid Cap BlendMid cap companies, with market capitalization in the range of $2 billion and $10 billion, offer investors many things that small and large companies don't, including less risk and higher growth opportunities. Thus they have a nice balance of growth potential and stability.

Typically holding a combination of both growth and value stocks, blend ETFs also demonstrate qualities seen in value and growth investments.

CostsExpense ratios are an important factor in the return of an ETF and in the long term, cheaper funds can significantly outperform their more expensive counterparts, other things remaining the same.

Annual operating expenses for this ETF are 0.24%, putting it on par with most peer products in the space.

It has a 12-month trailing dividend yield of 1.94%.

Sector Exposure and Top HoldingsIt is important to delve into an ETF's holdings before investing despite the many upsides to these kinds of funds like diversified exposure, which minimizes single stock risk. And, most ETFs are very transparent products that disclose their holdings on a daily basis.

This ETF has heaviest allocation to the Healthcare sector -- about 12.4% of the portfolio. Industrials and Consumer Staples round out the top three.

Looking at individual holdings, Ciena Corp Common Stock (CIEN) accounts for about 0.72% of total assets, followed by Lumentum Holdings Inc (LITE) and Western Digital Corp (WDC).

The top 10 holdings account for about 5.35% of total assets under management.

Performance and RiskJPME seeks to match the performance of the Russell Midcap Diversified Factor Index before fees and expenses. The JP Morgan Diversified Factor US Mid Cap Equity Index utilizes a rules-based approach that combines risk-based portfolio construction with multi-factor security selection, including value, quality and momentum factors.

The ETF has added about 8.84% so far this year and is up roughly 4.64% in the last one year (as of 12/15/2025). In the past 52-week period, it has traded between $89.28 and $110.89.

The ETF has a beta of 0.94 and standard deviation of 14.62% for the trailing three-year period. With about 355 holdings, it effectively diversifies company-specific risk.

AlternativesJPMorgan Diversified Return U.S. Mid Cap Equity ETF carries a Zacks ETF Rank of 3 (Hold), which is based on expected asset class return, expense ratio, and momentum, among other factors. Thus, JPME is a reasonable option for those seeking exposure to the Style Box - Mid Cap Blend area of the market. Investors might also want to consider some other ETF options in the space.

The Vanguard Mid-Cap ETF (VO) and the iShares Core S&P Mid-Cap ETF (IJH) track a similar index. While Vanguard Mid-Cap ETF has $90.47 billion in assets, iShares Core S&P Mid-Cap ETF has $102.98 billion. VO has an expense ratio of 0.04% and IJH charges 0.05%.

Bottom-LinePassively managed ETFs are becoming increasingly popular with institutional as well as retail investors due to their low cost, transparency, flexibility and tax efficiency. They are excellent vehicles for long term investors.

To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.

Uber Technologies' (NYSE:UBER) has seen a decline of approximately 10% over the last month—from about $94 to $84—despite the firm announcing another strong quarter, highlighting that the recent downturn is more influenced by market sentiment than by its fundamentals. This decrease positions Uber close to a one-month low, even though the larger tech sector has also faced setbacks, with numerous high-growth companies experiencing drops ranging from 8% to 15% within the same timeframe.

The Schwab Fundamental U.S. Broad Market ETF (FNDB - Free Report) made its debut on 08/13/2013, and is a smart beta exchange traded fund that provides broad exposure to the Style Box - All Cap Value category of the market.

What Are Smart Beta ETFs?The ETF industry has traditionally been dominated by products based on market capitalization weighted indexes that are designed to represent the market or a particular segment of the market.

Because market cap weighted indexes provide a low-cost, convenient, and transparent way of replicating market returns, they work well for investors who believe in market efficiency.

If you're the kind of investor who would rather try and beat the market through good stock selection, then smart beta funds are your best choice; this fund class is known for tracking non-cap weighted strategies.

By attempting to pick stocks that have a better chance of risk-return performance, non-cap weighted indexes are based on certain fundamental characteristics, or a combination of such.

This area offers many different investment choices, such as simplest equal-weighting, fundamental weighting and volatility/momentum based weighting methodologies; however, not all of these strategies can deliver superior results.

Fund Sponsor & IndexThe fund is managed by Charles Schwab. FNDB has been able to amass assets over $1.04 billion, making it one of the larger ETFs in the Style Box - All Cap Value. FNDB, before fees and expenses, seeks to match the performance of the Russell RAFI US Index.

The RAFI Fundamental High Liquidity US All Index measures the performance of U.S. based companies based on their fundamental size and weight.

Cost & Other ExpensesWhen considering an ETF's total return, expense ratios are an important factor. And, cheaper funds can significantly outperform their more expensive cousins in the long term if all other factors remain equal.

With one of the cheaper products in the space, this ETF has annual operating expenses of 0.25%.

It's 12-month trailing dividend yield comes in at 1.61%.

Sector Exposure and Top HoldingsMost ETFs are very transparent products, and disclose their holdings on a daily basis. ETFs also offer diversified exposure, which minimizes single stock risk, though it's still important for investors to research a fund's holdings.

This ETF has heaviest allocation in the Information Technology sector - about 17.8% of the portfolio. Financials and Healthcare round out the top three.

Looking at individual holdings, Apple Inc (AAPL) accounts for about 4.3% of total assets, followed by Microsoft Corp (MSFT) and Alphabet Inc Class A (GOOGL).

Its top 10 holdings account for approximately 19.07% of FNDB's total assets under management.

Performance and RiskThe ETF has added roughly 16.73% so far this year and is up roughly 12.85% in the last one year (as of 12/15/2025). In the past 52-week period, it has traded between $20.36 and $26.90

The ETF has a beta of 0.90 and standard deviation of 13.70% for the trailing three-year period, making it a medium risk choice in the space. With about 1640 holdings, it effectively diversifies company-specific risk .

AlternativesSchwab Fundamental U.S. Broad Market ETF is a reasonable option for investors seeking to outperform the Style Box - All Cap Value segment of the market. However, there are other ETFs in the space which investors could consider.

Fidelity High Dividend ETF (FDVV) tracks Fidelity Core Dividend Index and the iShares Core S&P U.S. Value ETF (IUSV) tracks S&P 900 Value Index. Fidelity High Dividend ETF has $7.73 billion in assets, iShares Core S&P U.S. Value ETF has $24.43 billion. FDVV has an expense ratio of 0.16% and IUSV changes 0.04%.

Investors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the Style Box - All Cap Value

Bottom LineTo learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.

If you're interested in broad exposure to the Financials - Broad segment of the equity market, look no further than the Invesco KBW High Dividend Yield Financial ETF (KBWD - Free Report) , a passively managed exchange traded fund launched on December 2, 2010.

An increasingly popular option among retail and institutional investors, passively managed ETFs offer low costs, transparency, flexibility, and tax efficiency; they are also excellent vehicles for long term investors.

Sector ETFs also provide investors access to a broad group of companies in particular sectors that offer low risk and diversified exposure. Financials - Broad is one of the 16 broad Zacks sectors within the Zacks Industry classification. It is currently ranked 2, placing it in top 13%.

Index DetailsThe fund is sponsored by Invesco. It has amassed assets over $425.56 million, making it one of the average sized ETFs attempting to match the performance of the Financials - Broad segment of the equity market. KBWD seeks to match the performance of the KBW Nasdaq Financial Sector Dividend Yield Index before fees and expenses.

The KBW Nasdaq Financial Sector Dividend Yield Index is a dividend yield weighted index seeking to reflect the performance of approximately 24 to 40 publicly listed financial companies engaged in the business of providing financial services and products, including banking, insurance and diversified financial services, in the US.

CostsSince cheaper funds tend to produce better results than more expensive funds, assuming all other factors remain equal, it is important for investors to pay attention to an ETF's expense ratio.

Annual operating expenses for this ETF are 4.93%, making it one of the most expensive products in the space.

It has a 12-month trailing dividend yield of 12.62%.

Sector Exposure and Top HoldingsWhile ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. And, most ETFs are very transparent products that disclose their holdings on a daily basis.

This ETF has heaviest allocation in the Financials sector -- about 100% of the portfolio.

Looking at individual holdings, Orchid Island Capital Inc (ORC) accounts for about 5.33% of total assets, followed by Armour Residential Reit Inc (ARR) and Dynex Capital Inc (DX).

The top 10 holdings account for about 38.43% of total assets under management.

Performance and RiskThe ETF return is roughly 5.49% so far this year and is up about 1.83% in the last one year (as of 12/15/2025). In that past 52-week period, it has traded between $12.37 and $15.69.

The ETF has a beta of 1.09 and standard deviation of 18.91% for the trailing three-year period, making it a medium risk choice in the space. With about 43 holdings, it has more concentrated exposure than peers.

AlternativesInvesco KBW High Dividend Yield Financial ETF sports a Zacks ETF Rank of 4 (Sell), which is based on expected asset class return, expense ratio, and momentum, among other factors. KBWD, then, is not the best option for investors seeking exposure to the Financials ETFs segment of the market. Instead, there are better ETFs in the space to consider.

Vanguard Financials ETF (VFH) tracks MSCI US Investable Market Financials 25/50 Index and the State Street Financial Select Sector SPDR ETF (XLF) tracks Financial Select Sector Index. Vanguard Financials ETF has $13.41 billion in assets, State Street Financial Select Sector SPDR ETF has $53.41 billion. VFH has an expense ratio of 0.09%, and XLF charges 0.08%.

Bottom LineTo learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.

The Franklin U.S. Large Cap Multifactor Index ETF (FLQL - Free Report) made its debut on 04/26/2017, and is a smart beta exchange traded fund that provides broad exposure to the Style Box - Large Cap Blend category of the market.

What Are Smart Beta ETFs?The ETF industry has long been dominated by products based on market cap weighted indexes, a strategy created to reflect the market or a particular market segment.

Market cap weighted indexes work great for investors who believe in market efficiency. They provide a low-cost, convenient and transparent way of replicating market returns.

However, some investors believe in the possibility of beating the market through exceptional stock selection, and choose a different type of fund that tracks non-cap weighted strategies: smart beta.

By attempting to pick stocks that have a better chance of risk-return performance, non-cap weighted indexes are based on certain fundamental characteristics, or a combination of such.

The smart beta space gives investors many different choices, from equal-weighting, one of the simplest strategies, to more complicated ones like fundamental and volatility/momentum based weighting. However, not all of these methodologies have been able to deliver remarkable returns.

Fund Sponsor & IndexThe fund is sponsored by Franklin Templeton Investments. It has amassed assets over $1.67 billion, making it one of the larger ETFs in the Style Box - Large Cap Blend. Before fees and expenses, this particular fund seeks to match the performance of the LibertyQ US Large Cap Equity Index.

The LibertyQ US Large Cap Equity Index seeks to achieve a lower level of risk and higher risk-adjusted performance than the Russell 1000 Index over the long term by applying a multi-factor selection process, which is designed to select equity securities from the Russell 1000 Index that have favorable exposure to four investment style factors quality, value, momentum and low volatility.

Cost & Other ExpensesSince cheaper funds tend to produce better results than more expensive funds, assuming all other factors remain equal, it is important for investors to pay attention to an ETF's expense ratio.

Annual operating expenses for this ETF are 0.15%, making it one of the cheaper products in the space.

It's 12-month trailing dividend yield comes in at 1.07%.

Sector Exposure and Top HoldingsWhile ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. And, most ETFs are very transparent products that disclose their holdings on a daily basis.

Representing 35.5% of the portfolio, the fund has heaviest allocation to the Information Technology sector; Consumer Discretionary and Financials round out the top three.

Looking at individual holdings, Nvidia Corp (NVDA) accounts for about 7.12% of total assets, followed by Apple Inc (AAPL) and Microsoft Corp (MSFT).

FLQL's top 10 holdings account for about 37.1% of its total assets under management.

Performance and RiskSo far this year, FLQL has added about 19.33%, and is up roughly 15.62% in the last one year (as of 12/15/2025). During this past 52-week period, the fund has traded between $50.10 and $70.51.

FLQL has a beta of 0.96 and standard deviation of 14.94% for the trailing three-year period. With about 217 holdings, it effectively diversifies company-specific risk .

AlternativesFranklin U.S. Large Cap Multifactor Index ETF is an excellent option for investors seeking to outperform the Style Box - Large Cap Blend segment of the market. There are other ETFs in the space which investors could consider as well.

SPDR S&P 500 ETF (SPY) tracks S&P 500 Index and the Vanguard S&P 500 ETF (VOO) tracks S&P 500 Index. SPDR S&P 500 ETF has $713.38 billion in assets, Vanguard S&P 500 ETF has $820.63 billion. SPY has an expense ratio of 0.09% and VOO changes 0.03%.

Investors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the Style Box - Large Cap Blend

Bottom LineTo learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.

Launched on February 5, 2001, the iShares Biotechnology ETF (IBB - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

Passively managed ETFs are becoming increasingly popular with institutional as well as retail investors due to their low cost, transparency, flexibility and tax efficiency. They are excellent vehicles for long term investors.

Sector ETFs also provide investors access to a broad group of companies in particular sectors that offer low risk and diversified exposure. Healthcare - Biotech is one of the 16 broad Zacks sectors within the Zacks Industry classification. It is currently ranked 5, placing it in top 31%.

Index DetailsThe fund is sponsored by Blackrock. It has amassed assets over $8.6 billion, making it one of the largest ETFs attempting to match the performance of the Healthcare - Biotech segment of the equity market. IBB seeks to match the performance of the Nasdaq Biotechnology Index before fees and expenses.

The ICE Biotechnology Index contains securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceuticals.

CostsCost is an important factor in selecting the right ETF, and cheaper funds can significantly outperform their more expensive counterparts if all other fundamentals are the same.

Annual operating expenses for this ETF are 0.44%, making it on par with most peer products in the space.

It has a 12-month trailing dividend yield of 0.16%.

Sector Exposure and Top HoldingsEven though ETFs offer diversified exposure which minimizes single stock risk, it is still important to look into a fund's holdings before investing. Luckily, most ETFs are very transparent products that disclose their holdings on a daily basis.

This ETF has heaviest allocation in the Healthcare sector -- about 100% of the portfolio.

Looking at individual holdings, Amgen Inc (AMGN) accounts for about 7.83% of total assets, followed by Vertex Pharmaceuticals Inc (VRTX) and Gilead Sciences Inc (GILD).

The top 10 holdings account for about 48.98% of total assets under management.

Performance and RiskSo far this year, IBB has added roughly 28.3%, and was up about 23.26% in the last one year (as of 12/15/2025). During this past 52-week period, the fund has traded between $112.02 and $173.83.

The ETF has a beta of 0.76 and standard deviation of 19.04% for the trailing three-year period, making it a high risk choice in the space. With about 253 holdings, it effectively diversifies company-specific risk.

AlternativesiShares Biotechnology ETF carries a Zacks ETF Rank of 3 (Hold), which is based on expected asset class return, expense ratio, and momentum, among other factors. Thus, IBB is a good option for those seeking exposure to the Health Care ETFs area of the market. Investors might also want to consider some other ETF options in the space.

First Trust NYSE Arca Biotechnology ETF (FBT) tracks NYSE Arca Biotechnology Index and the State Street SPDR S&P Biotech ETF (XBI) tracks S&P Biotechnology Select Industry Index. First Trust NYSE Arca Biotechnology ETF has $1.33 billion in assets, State Street SPDR S&P Biotech ETF has $8.04 billion. FBT has an expense ratio of 0.54%, and XBI charges 0.35%.

Bottom LineTo learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A year ago, the narrative was simple: OpenAI would eat Google’s lunch. ChatGPT was the future of search, and Alphabet (NASDAQ:GOOGL) was a lumbering giant about to be disrupted. Fast forward to December 2025, and the story has flipped. Google just delivered its first $100 billion quarter, the stock has more than doubled from its early-2025 lows, and real-money prediction markets give the company 89% odds of having the best AI model by year-end. The question isn’t whether Google survived the AI threat. It’s whether anyone can stop them now.

The Numbers Tell the Story
Start with Q3 2025. Revenue hit $102.35 billion, up 26% year-over-year. What matters is the quality of that growth. Operating margins sit at 30.5%, profit margins at 32%, and return on equity at 35%. Google is printing money at a scale and efficiency that would make a toll bridge operator jealous. Earnings grew 35% despite the company already sitting at $385 billion in annual revenue. That’s not supposed to happen.

Compare that to the competition. Microsoft (NASDAQ:MSFT) grew revenue 18% in Q1 2026 but took a $3.1 billion hit on OpenAI investment losses: a $0.41 drag on EPS. Azure is growing at 40%, but the company is paying dearly for its AI bet. Amazon (NASDAQ:AMZN) saw AWS growth re-accelerate to 20%, but operating margins remain stuck at 11%. Apple (NASDAQ:AAPL) grew just 8%, missing revenue estimates. Meta (NASDAQ:META) matched Google’s 26% revenue growth but got hit with a $15.93 billion tax charge that obliterated reported earnings.

The AI Advantage
Here’s where Google separated from the pack. While Microsoft was writing checks to OpenAI and Meta was burning cash on Reality Labs, Google already owned the infrastructure. Sundar Pichai laid it out on the Q3 call: “Our full stack approach to AI is delivering strong momentum and we’re shipping at speed, including the global rollout of AI Overviews and AI Mode in Search in record time.”

The company didn’t need to acquire AI capability. It built TPUs, trained models in-house, and integrated Gemini across 650 million monthly active users. Google Cloud grew 34% to $15.2 billion, faster than AWS and with better margins. The prediction market data is stunning: 89% probability that Google has the best AI model by year-end. OpenAI sits at 7%.

The Moat Widens
What makes Google potentially unstoppable isn’t just current performance, it’s the structural advantages compounding. The company has zero analyst sell ratings. The stock trades at 30.5x earnings, which looks reasonable given 35% earnings growth. Capital expenditures will hit $91-93 billion in 2025, but unlike competitors, Google is generating the cash flow to fund it internally while maintaining 32% profit margins.

The bears were wrong about AI disruption. Google didn’t just survive. It turned the threat into an accelerant. Whether that makes them truly unstoppable depends on whether you think anyone can match their combination of scale, profitability, and technical capability. Right now, the market is betting they can’t.

11h05 ▪
4
min read ▪ by
James G.

Summarize this article with:

BONK continues to face steady selling pressure, with price action offering no clear signs of a rebound. Recent moves reflect hesitation rather than strength, leaving traders cautious. As expected, the market remains without a clear direction, and volatility stays muted.

In brief

BONK trades sideways after a sharp drop, with weak momentum and cautious sentiment keeping the price locked in a narrow range near support.
Daily charts show lower highs and lows, with bearish flag consolidation suggesting downside risk still dominates for traders in the short term.
Key resistance near $0.000001025 continues to attract sellers, limiting upside and favoring short-side interest over longs in rallies.
Falling volume and open interest point to position unwinding, as traders stay sidelined awaiting clearer direction from price action.

Defensive Sentiment Keeps BONK Rangebound After Recent Decline
Following a sharp decline, BONK has entered a sideways phase, signaling uncertainty rather than stability. Selling pressure has eased slightly, but buyers have yet to show strong conviction. After leading memecoin gains in July, the asset’s short-term price action indicates a lack of momentum. As such, this has kept the token confined to a narrow range, with sentiment remaining defensive.

Although Q4 has historically been a stronger period for the memecoin, higher-timeframe charts still point to bearish conditions. Crypto analyst CryptoPulse noted that the daily structure continues to print lower highs and lower lows, with support from a series of large red candles.

The ongoing consolidation appears consistent with a bearish flag, a pattern that often precedes further downside. Quiet trading has not changed the broader trend, and patience remains limited among traders waiting for signs of a reversal.

Bearish Indicators Dominate as Price Fails to Regain Momentum
Market data continues to support a weak outlook, with multiple indicators pointing in the same direction:

Price sentiment remains bearish, with the Fear & Greed Index at 23, reflecting extreme fear.
The token has fallen roughly 76% over the past year and remains 84% below its all-time high.
Performance continues to lag behind Bitcoin, Ethereum, and most top-100 crypto assets.
Price remains below the 200-day simple moving average.
Only 11 green days have occurred over the past 30 sessions, signaling limited buying interest.

Attempts to push above key levels have repeatedly stalled, as resistance continues to cap upside attempts. Analysts are closely watching the $0.000001025 area, which has acted as a firm supply zone. 

Any move toward that level is likely to draw sellers looking for short exposure rather than long positions. More so, a failure to hold current support would confirm the bearish flag and could accelerate downside movement.

From a technical perspective, BONK trades below all major exponential moving averages, with the 20-day EMA acting as immediate resistance. Longer-term EMAs remain positioned above price, reinforcing the downtrend. The MACD stays below the zero line, and while downside momentum has slowed, no bullish crossover has emerged.

Derivatives data reflect a similar trend. Trading volume and open interest have declined, suggesting position unwinding rather than new market participation. Funding rates remain slightly positive, though long-side leverage stays limited. For now, traders appear to be on the sidelines, waiting for clearer signals before taking on risk.

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

James G.

James Godstime is a crypto journalist and market analyst with over three years of experience in crypto, Web3, and finance. He simplifies complex and technical ideas to engage readers. Outside of work, he enjoys football and tennis, which he follows passionately.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.

Mon, 15/12/2025 - 10:13

While the market performance of XRP is far from perfect, the institutional flow dynamic is certainly bringing a lot of hope.

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

With nearly $1.00 billion in net inflows over the last 30 days, XRP recently achieved a significant on-chain and market milestone. That figure is significant because it shows ongoing capital investment rather than a one-day media frenzy.  

XRP ETF's run upXRP-linked investment products have received about $990.00 million in net inflows on the capital side, and daily inflows are still positive. Currently, total net assets exceed $1.18 billion, or nearly 1% of XRP’s total market capitalization. That might not seem like much, but in terms of ETFs and trusts, it is. 

XRP/USDT Chart by TradingViewEven though prices are dropping, products like Grayscale, Bitwise, Franklin and others continue to see consistent allocation. This divergence, capital entering the market while prices decline, often precedes regime changes rather than sudden pumps.

HOT Stories

The chart, which is objectively poor, comes next. Since the October breakdown, XRP has been moving inside a downward channel. After losing important moving averages (50-, 100- and 200-day), the price is currently hovering around $2.00.

You Might Also Like

RSI and other momentum indicators are trapped in the low- to mid-40s, indicating bearish pressure rather than complete surrender. Volume has decreased, indicating a decrease in selling pressure rather than an increase in it.

XRP's price performanceAt $2.00, the psychological and technical critical level has been reached. A clean daily close below it would probably cause a quick move in the direction of the $1.80-$1.70 range, which is where previous demand is located. That is the bearish continuation scenario, which is still very much a possibility if overall market sentiment continues to be risk-averse. It depends on absorption in the other case.

If inflows continue and XRP stays above $2.00, the current range begins to resemble accumulation rather than distribution. The first indication that sellers are losing control would be the reclamation of $2.20 to $2.25, which would allow for a return to $2.50.

Money is still coming in even though the price appears ugly. XRP is compressed money, not dead money. Investors should anticipate volatility at first, followed by clarity. Hype will not make the next big move; instead, it will depend on whether or not this capital flow eventually drives up prices.

Related articles

Darius Baruo
Dec 15, 2025 11:15

CRV price prediction shows potential 26% upside to $0.48 within 30-45 days as MACD turns bullish and consolidation near $0.39 pivot suggests breakout imminent.

CRV Price Prediction Summary
• CRV short-term target (1 week): $0.42 (+10.5%)
• Curve medium-term forecast (1 month): $0.45-$0.48 range

• Key level to break for bullish continuation: $0.45
• Critical support if bearish: $0.37

Recent Curve Price Predictions from Analysts
The latest CRV price prediction consensus from leading analysts shows cautious optimism for the protocol's native token. Blockchain.News presents the most bullish Curve forecast with a $0.48 medium-term target, representing a compelling 26% upside from current levels. This prediction aligns with technical consolidation patterns observed around the crucial $0.39 pivot point.

CoinMarketCap's AI analysis supports this bullish thesis, highlighting a recent MACD crossover and RSI recovery from oversold conditions. However, short-term models from CoinLore and Bitget suggest more modest movements, with targets clustering around $0.39-$0.40 for the immediate term.

The divergence in predictions reflects the current uncertainty in CRV's price action, but the medium-term technical setup appears increasingly favorable for upside continuation.

CRV Technical Analysis: Setting Up for Breakout
The Curve technical analysis reveals a compelling setup for potential upside acceleration. CRV's current position at $0.38 sits just below the critical $0.39 pivot level, with the MACD histogram showing early bullish momentum at 0.0013. This positive histogram reading suggests the recent downtrend may be exhausting.

Key technical factors supporting the bullish CRV price prediction include:

The RSI at 41.90 provides ample room for upward movement before reaching overbought territory. CRV's position within the Bollinger Bands at 0.23 indicates the token is trading in the lower portion of its recent range, historically a favorable entry zone for swing traders.

Volume analysis shows sustained interest at $6.06 million in 24-hour trading, providing adequate liquidity for any breakout attempt. The proximity to the lower Bollinger Band at $0.36 also suggests limited downside risk from current levels.

Curve Price Targets: Bull and Bear Scenarios
Bullish Case for CRV
The primary bullish scenario targets the $0.45 resistance level first, representing a 18% gain from current prices. This CRV price target aligns with the immediate resistance identified in the technical data and would confirm the breakout above the $0.39-$0.42 consolidation zone.

Extended bullish targets reach $0.48, matching Blockchain.News's medium-term Curve forecast. This level would represent a successful test of the upper Bollinger Band region and could trigger additional momentum toward the $0.60 strong resistance zone.

For this scenario to materialize, CRV needs to reclaim the 7-day SMA at $0.39 and maintain above this level with increasing volume. A decisive break above $0.42 would likely accelerate the move toward $0.45-$0.48.

Bearish Risk for Curve
The bearish scenario emerges if CRV fails to hold the $0.37 immediate support level. A breakdown below this threshold could trigger selling toward the $0.36 strong support, representing the 52-week low territory.

Technical warning signs for the bearish case include a failure to generate positive MACD momentum or a breakdown below the lower Bollinger Band at $0.36. The significant distance from the 200-day SMA at $0.66 also indicates the longer-term trend remains challenged.

Risk factors to monitor include broader DeFi sector weakness, reduced trading volume below $5 million daily, and failure to reclaim the $0.39 pivot within the next 5-7 trading days.

Should You Buy CRV Now? Entry Strategy
The current technical setup suggests a measured approach to the buy or sell CRV decision. Conservative buyers should wait for a confirmed break above $0.39 with volume expansion before initiating positions. This would provide confirmation that the consolidation phase is ending.

Aggressive traders might consider accumulating between $0.37-$0.38, using the strong support at $0.36 as a stop-loss reference point. This approach offers a favorable risk-reward ratio with upside targets at $0.42 and $0.48.

Position sizing should remain conservative given the medium confidence level in current predictions. Consider allocating no more than 2-3% of portfolio value to CRV until the technical picture becomes clearer above $0.42.

CRV Price Prediction Conclusion
The CRV price prediction for the next 30-45 days targets the $0.45-$0.48 range, representing potential gains of 18-26% from current levels. This forecast carries medium confidence based on improving MACD momentum and oversold RSI conditions.

Key indicators to watch for confirmation include sustained trading above $0.39, MACD line crossing above the signal line, and volume expansion on any breakout attempts. Invalidation signals would include a break below $0.37 or failure to reclaim $0.39 within the next week.

The timeline for this Curve forecast extends through January 2026, with initial targets of $0.42 expected within 7-10 days if the bullish scenario develops. Traders should monitor the $0.37-$0.48 range closely as CRV attempts to establish a new directional bias.

Image source: Shutterstock

crv price analysis
crv price prediction